CYTK vs ONC
Cytokinetics, Incorporated · BeOne Medicines AG
Relative return (rebased to 100)
Key stats
| Metric | CYTK | ONC |
|---|---|---|
| Price | $72.09 | $366.73 |
| Market Cap | $8.97B | $530.02B |
| P/E | — | 1847.19 |
| P/B | — | 111.34 |
| P/S | 101.89 | 99.20 |
| ROE | — | 6.0% |
| Net Margin | -891.6% | 5.4% |
| Gross Margin | — | 87.5% |
| Revenue Growth | 376.6% | 40.2% |
| Dividend Yield | — | — |
| EPS | -$6.31 | $0.20 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.